Patents by Inventor Mohan Shenoy

Mohan Shenoy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120115746
    Abstract: Compositions and methods for diagnosing and treating CVH and CVH-associated disorders are disclosed. Genes differentially expressed in CVH tissues relative to normal tissues are identified. The genes and the gene products (i.e., the polynucleotides transcribed from and polypeptides encoded by the genes) can be used as markers of CVH. The genes and the gene products can also be used to screen agents that modulate the gene expression or the activities of the gene products.
    Type: Application
    Filed: December 5, 2011
    Publication date: May 10, 2012
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Pankaj Pasricha, Mohan Shenoy, John Winston
  • Patent number: 8071652
    Abstract: A treatment to differentially regulate the expression of genes related to irritable bowel syndrome is provided.
    Type: Grant
    Filed: August 23, 2004
    Date of Patent: December 6, 2011
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Pankaj Pasricha, Mohan Shenoy, John Winston
  • Patent number: 7541156
    Abstract: The invention provides a method of decreasing pain in a subject, the method comprising administering to the subject an amount of a compound effective to decrease activation of protease activated receptor-2.
    Type: Grant
    Filed: April 18, 2005
    Date of Patent: June 2, 2009
    Inventors: Pankaj J. Pasricha, Willemijntje A. Hoogerwerf, John Winston, Maria-Adelaide Micci, Helen Hellmich, Mohan Shenoy
  • Publication number: 20050130189
    Abstract: Compositions and methods for diagnosing and treating CVH and CVH-associated disorders are disclosed. Genes differentially expressed in CVH tissues relative to normal tissues are identified. The genes and the gene products (i.e., the polynucleotides transcribed from and polypeptides encoded by the genes) can be used as markers of CVH. The genes and the gene products can also be used to screen agents that modulate the gene expression or the activities of the gene products.
    Type: Application
    Filed: August 23, 2004
    Publication date: June 16, 2005
    Inventors: Pankaj Pasricha, Mohan Shenoy, John Winston